290 likes | 302 Views
LUNG TRANSPLANTATION. Pediatric Recipients. AGE DISTRIBUTION OF PEDIATRIC LUNG RECIPIENTS (Transplants: January 1986 - June 2002). AGE DISTRIBUTION FOR DONORS OF PEDIATRIC LUNG RECIPIENTS (Transplants: January 1986 - June 2002). 83. 85. 82. 70. 65. 67. 57. 50. 47. 45. 40. 20. 6.
E N D
LUNG TRANSPLANTATION Pediatric Recipients
AGE DISTRIBUTION OF PEDIATRIC LUNG RECIPIENTS (Transplants: January 1986 - June 2002)
AGE DISTRIBUTION FOR DONORS OFPEDIATRIC LUNG RECIPIENTS(Transplants: January 1986 - June 2002)
83 85 82 70 65 67 57 50 47 45 40 20 6 3 4 1 AGE DISTRIBUTION OF PEDIATRIC LUNG RECIPIENTSBy Year of Transplant Number of Transplants
PEDIATRIC LUNG TRANSPLANTATION: Indications(Transplants: January 1991 - June 2002)
PEDIATRIC LUNG TRANSPLANTATIONActuarial Survival for Congenital Diagnosis(Transplants: January 1990 – June 2001)
PEDIATRIC LUNG TRANSPLANTATIONActuarial Survival by Procedure Type(Transplants: January 1990 - June 2001) P = 0.003
PEDIATRIC LUNG TRANSPLANTATIONActuarial Survivalby Age Group(Transplants: January 1990 - June 2001)
PEDIATRIC LUNG TRANSPLANTATIONConditional Actuarial Survival by Age Group(Transplants: January 1990 - June 2001) HALF-LIFE <1 Year: ½-life = 7.1 Years 1-10 Years: ½-life = 5.9 Years 11-17 Years: ½-life = 5.6 Years
PEDIATRIC LUNG TRANSPLANTATION Actuarial Survival by Era(Transplants: January 1988 - June 2001)
PEDIATRIC LUNG TRANSPLANTATIONActuarial Survival by Procedure Type Diagnosis: PPH(Transplants: January 1990 - June 2001) P = 0.002
PEDIATRIC LUNG RECIPIENTS Functional Status (Follow-ups: April 1994-June 2002)
PEDIATRIC LUNG RECIPIENTS Rehospitalization Post-transplant(Follow-ups: April 1994 - June 2002)
PEDIATRIC LUNG RECIPIENTS Induction ImmunosuppressionFor follow-ups between January 2000 and June 2002
PEDIATRIC LUNG RECIPIENTSInduction Immunosuppression (Follow-ups: January 2000 - June 2002)
PEDIATRIC LUNG RECIPIENTSMaintenance Immunosuppression at Any Time During Follow-up PeriodFor follow-ups between January 2000 and June 2002 NOTE: Different patients are analyzed in Year 1 and Year 5
PEDIATRIC LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between January 2000 and June 2002 NOTE: Different patients are analyzed in Year 1 and Year 5
PEDIATRIC LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between January 2000 and June 2002 1 Year Follow-up (N = 86) 5 Year Follow-up (N = 55) NOTE: Different patients are analyzed in Year 1 and Year 5
PEDIATRIC LUNG RECIPIENTSMaintenance Immunosuppression Drug Combinations at Time of Follow-up Report For follow-ups between January 2000 and June 2002 NOTE: Different patients are analyzed in Year 1 and Year 5
POST-LUNG TRANSPLANT MORBIDITY FOR PEDIATRICSCumulative Prevalence in Survivors within 1 Year Post-Transplant (Follow-ups: April 1994-June 2002)
POST-LUNG TRANSPLANT MORBIDITY FOR PEDIATRICSCumulative Prevalence in Survivors within 5 Years Post-Transplant (Follow-ups: April 1994-June 2002)
Freedom from Bronchiolitis ObliteransFor Pediatric Lung Recipients(Follow-ups: April 1994 - June 2002)
Freedom from Severe Renal Dysfunction*For Pediatric Lung Recipients(Follow-ups: April 1994 - June 2002) * Severe renal dysfunction = Creatinine > 2.5 mg/dl, dialysis or renal transplant
MALIGNANCY POST-LUNG TRANSPLANTATION FOR PEDIATRICSCumulative Incidence for Survivors(Follow-ups: April 1994 - June 2002)
Freedom from MalignancyFor Pediatric Lung Recipients(Follow-ups: April 1994 - June 2002)
PEDIATRIC LUNG RECIPIENTSRelationship of Diabetes and Cystic FibrosisTransplants: April 1994 – June 2001 *p < 0.0001 **p < 0.0001
PEDIATRIC LUNG TRANSPLANT RECIPIENTS: Cause Of Death(Deaths: January 1992- June 2002)